Insomnia medication use and the probability of an accidental event in an older adult population

Drug, Healthcare and Patient Safety

Volumn 2, Issue 1, 2010, Pages 225-232

  Avidan, Alon Y ^a   Palmer, Liisa A ^b   Doan, Justin F ^c   Baran, Robert W ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b THOMSON REUTERS   (United Kingdom)

^c TAKEDA PHARMACEUTICALS   (United States)

Author keywords

Accidental events; Benzodiazepine receptor agonist; Insomnia; Melatonin receptor agonist; Older adults

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE;

ACCIDENT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DRUG CLASSIFICATION; DRUG EFFICACY; DRUG USE; FEMALE; HIGH RISK PATIENT; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PATIENT SAFETY; POPULATION RESEARCH; PRESCRIPTION; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT;

EID: 78650709344     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: 10.2147/DHPS.S14955     Document Type: Article

References (31)

1. Roehrs T, Zorick F, Roth T. Transient and short-term insomnias. In: Kryger M, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd edition Philadelphia, PA: W.B. Saunders and Company; 2000:624-632.
2. Roth T, Roehrs T. Insomnia: epidemiology, characteristics, and consequences. Clin Cornerstone. 2003;5:5-15.
3. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Prevalence and correlates. Arch Gen Psychiatry. 1985;42:225-232.
4. Foley D, Ancoli-Israel S, Britz P, Walsh J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56:497-502.
5. Ancoli-Israel S. Insomnia in the elderly: a review for the primary care practitioner. Sleep. 2000;23 Suppl 1:S23-S30.
6. Folks DG, Burke WJ. Psychotherapeutic agents in older adults. Sedative hypnotics and sleep. Clin Geriatr Med. 1998;14:67-86.
7. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep. 1995;18:425-432.
8. Erman MK. Therapeutic options in the treatment of insomnia. J Clin Psychiatry. 2005;66 Suppl 9:18-23.
9. Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother. 2006;4:168-192.
10. Landi F, Onder G, Cesari M, Barillaro C, Russo A, Bernabei R. Psychotropic medications and risk for falls among community-dwelling frail older people: an observational study. J Gerontol A Biol Sci Med Sci. 2005;60:622-626.
11. Glass J, Lanctot K, Herrmann N, Sproule B, Busto U. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331:1169-1173.
12. Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 2003;26:261-282.
13. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev. 2004;8:309-325.
14. Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J. Zolpidem use and hip fractures in older people. J Am Geriatr Soc. 2001;49:1685-1690.
15. Menzin J, Lang KM, Levy P, Levy E. A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France. Pharmacoeconomics. 2001;19:69-78.
16. Benca RM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv. 2005;56:332-343.
17. Erman M, Seiden D, Zammit G, Sainati S, Zhang J. An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia. Sleep Med. 2006;7:17-24.
18. Borja NL, Daniel KL. Ramelteon for the treatment of insomnia. Clin Ther. 2006;28:1540-1555.
19. Zammit G, Wang-Weigand S, Rosenthal M, Peng X. Effect of ramelteon on middle-of-the-night balance in older adults with chronic insomnia. J Clin Sleep Med. 2009;5:34-40.
20. Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Arch Gen Psychiatry. 2006;63:1149-1157.
21. Binder S. Injuries among older adults: the challenge of optimizing safety and minimizing unintended consequences. Inj Prev. 2002;8:IV2-IV4.
22. Aschkenasy MT, Rothenhaus TC. Trauma and falls in the elderly. Emerg Med Clin North Am. 2006;24:413-432.
23. Braver ER, Trempel RE. Are older drivers actually at higher risk of involvement in collisions resulting in deaths or non-fatal injuries among their passengers and other road users? Inj Prev. 2004;10:27-32.
24. Avidan AY, Fries B, James M, Szafara K, Wright G, Chervin R. Insomnia and hypnotic use, recorded in the minimum data set, as predictors of falls and hip fractures in Michigan nursing homes. J Am Geriatr Soc. 2005;53:955-962.
25. Balter MB, Uhlenhuth EH. New epidemiologic findings about insomnia and its treatment. J Clin Psychiatry. 1992;53 Suppl:34-39.
26. Cappellari L, Jenkins SP. Calculation of Multivariate Normal Probabilities By Simulation, With Applications to Maximum Simulated Likelihood Estimation. Available from: http://ssrn.com/abstract=900829. SSRN eLibrary. Published 2006 Accessed 2010 October 22.
27. WISQARS Nonfatal Injury Report. Available from: http://webappa.cdc.gov/sasweb/ncipc/nfirates2001.html. National Center for Injury Prevention and Control. Published 2009. Accessed 2010 October 22.
28. Nakata A, Ikeda T, Takahashi M, et al. Sleep-related risk of occupational injuries in Japanese small and medium-scale enterprises. Ind Health. 2005;43:89-97.
29. Leger D, Guilleminault C, Bader G, Levy E, Paillard M. Medical and socio-professional impact of insomnia. Sleep. 2002;25:625-629.
30. Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia. J Clin Sleep Med. 2007;3:495-504.
31. Roth T, Seiden D, Wang-Weigand S, Zhang J. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia. Curr Med Res Opin. 2007;23:1005-1014.